Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 373

pharmaceutical industry

Industry leaders, scientists, engineers, physicians, and investors from over 45 countries at Biomed Israel 2023 conference, Tel Aviv, May 16, 2023. (Alexander Elman)
May 17, 2023, 10:47 pm
At Biomed Israel conference, medical start-ups discuss challenges in reaching success
Companies dealing in life sciences and technology face tougher times ahead due to global economic uncertainty and political crisis at home
By Renee Ghert-Zand
The Eli Lilly corporate headquarters in Indianapolis, July 25, 2017. (AP Photo/Michael Conroy, File)
February 10, 2021, 5:41 pm
FDA okays antibody medicine said to cut COVID hospitalizations and deaths by 70%
US company Eli Lilly says 100,000 doses of its monoclonal treatment ‘ready immediately’ for distribution to high-risk patients aged 12 and older
By ToI Staff
A new patient arriving at the coronavirus ward of the Ziv Medical Center in the northern city of Safed, on January 7, 2020. (Cohen/Flash90)
January 26, 2021, 5:26 pm
US drugmaker says antibody treatment cuts COVID hospitalizations, deaths by 70%
Eli Lilly says phase 3 trial shows combination of two synthetic antibodies has ‘potential to be an important treatment in high-risk patients’
By AFP
North Carolina Attorney General Josh Stein speaks to reporters in Raleigh, North Carolina, August 3, 2017. (AP Photo/Emery Dalesio, File)
October 19, 2019, 12:13 pm
Local governments reject opioid settlement from Teva, other drugmakers
As states, localities tussle over terms of agreement, pharmaceutical firms say they’re unwilling to raise $48 billion offer
By GEOFF MULVIHILL
Illustrative image of a research lab. (Motortion; iStock by Getty Images)
October 16, 2019, 11:22 am
Pharmaceutical firm 89bio files for $70 million IPO
Herzliya- and San Francisco-based company with ties to medical giant Teva developing drug to treat NASH, a severe liver disease
By Luke Tress
The Horsham, Pennsylvania, offices of Teva Pharmaceuticals (AP Photo/George Widman)
July 18, 2019, 10:48 am
Federal data reveals extent of Teva’s role in fueling US opioid crisis
Israeli pharmaceutical giant produced less than 1% of the 76 billion oxycodone and hydrocodone pills; Sackler-owned Purdue produced about 3% in 2006-2012
By ToI Staff and AP
Dr. Guido Fanelli (right) entering police headquarters in Parma, Italy, for questioning in an alleged pharmaceutical kickback scheme, May 8, 2017. (AP/Marco Vasini)
May 29, 2019, 10:09 am
Purdue Pharma’s ‘Pain League’ allegedly pushed opioids in Italy
Drug company used Italian doctor, apparently employing practices that helped create US addiction crisis that has claimed 400,000 lives
By CLAIRE GALOFARO and Frances D'Emilio
Opioids, addiction, overdose (Illustrative, via iStock)
November 21, 2018, 7:37 pm
Sackler family faces possible criminal charges for role in opioid crisis
New York’s Suffolk County sues Jewish multi-billionaire owners of Purdue Pharma, the maker of OxyContin; Connecticut and NY consider pressing charges
By Eric Cortellessa
Mitsubishi Tanabe headquarters in Osaka, Japan. (screen capture: Google Street View)
July 24, 2017, 3:25 pm
Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b
Sale to Mitsubishi Tanabe is largest-ever of Israeli healthcare company; firm developing delivery methods for meds that fight Parkinson’s symptoms
By ToI Staff
The Jerusalem office of the Israeli drug company Teva Pharmaceuticals (Yonatan Sindel/Flash90)
August 3, 2016, 8:21 am
Teva completes $40b purchase of Allergan generics arm
CEO of Israeli drugs giant says deal, which puts it among top 10 global pharmaceutical firms, won’t push up medicine prices
By Joe Dyke
Teva's facility in Har Hotzvim, Jerusalem (Nati Shohat/Flash90)
From the WebOctober 2, 2015, 1:06 am
Teva to Buy Mexico’s Rimsa for About $2.3 Billion
NYSE Post: In an attempt to boost its presence in emerging markets, the Israeli pharma giant is buying a top Latin American drug firm
Worker at a Jerusalem pharmacy (Abir Sultan/Flash90)
August 24, 2015, 7:14 pm
Pharmacy offers Arabs career boost, enhanced ties with Jews
Over a third of Israeli pharmacists are members of Arab communities, providing a road – if a bumpy one – to the Israeli middle class
By David Shamah
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.